Skip to main content
Clinical Trials/CTRI/2022/01/039806
CTRI/2022/01/039806RecruitingPhase 3

Efficacy of repetitive transcranial magnetic stimulation in children and adolescents (5-18 years) with generalised dystonia :A randomised sham controlled trial

Child Neurology Division0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Children with age between 5 to 18 years of either sex.
  • 2.Presence of generalized dystonia
  • 3.On stable antidystonic pharmacotherapy and physiotherapy for atleast 3 months
  • 4. BFMDRS-M score of 52 or more

Exclusion Criteria

  • Primary Exclusion Criteria
  • 1.Children diagnosed with progressive neurometabolic or neurodegenerative disorder on the basis of course of illness, neuroimaging and standard diagnostic evaluation.
  • 2.Children with unilateral dystonia
  • 3.Children with uncontrolled epilepsy defined as 4 or more seizures in last 6 months
  • 4.Children with metallic implants anywhere in the body.
  • 5.Children who underwent DBS/ pallidotomy.
  • 6.Parents refusing consent for enrolment in the study.
  • Secondary Exclusion Criteria (to be applied at the end of observation phase I)
  • 1.Change in antidystonia, antipsychotic or antiseizure medications during the observation period
  • 2.Occurrence of seizure during the observation period
  • 3.Repeat BFMDRS-M score after 4 week observation <52

Investigators

Sponsor
Child Neurology Division

Similar Trials